Company Overview of Capsugel Inc.
Capsugel Inc. develops dosage forms and solutions for the healthcare industry around the world. It offers gelatin, alternate polymer, and liquid-filled capsules; hard gelatin, sprinkle, plus HPMC, fish gelatin, pearlescent, over-encapsulation, pre-clinical, liquid, soft gelatin, acid-resistant capsules; gelcaps; capsule in capsule technology products; and solid lipid pellet technology products. The company also provides precision powder micro-dosing systems, CFS liquid filling and sealing machines, profill manual capsule filling machines, and commercial scale capsule filling machines. The company develops drug delivery technology platform, enTRinsic, that offers enteric protection without th...
412 Mount Kemble Avenue
Morristown, NJ 07960
Founded in 1963
Key Executives for Capsugel Inc.
Chief Executive Officer and President
Chief Marketing Officer and Senior Vice President
Senior Vice President of Research and Development
Senior Director of Corporate Communications
Compensation as of Fiscal Year 2017.
Capsugel Inc. Key Developments
Lonza-Capsugel Presents at ProBiota 2018, Feb-08-2018 01:00 PM
Feb 5 18
Lonza-Capsugel Presents at ProBiota 2018, Feb-08-2018 01:00 PM. Venue: Plaza España, 6-8. 08014, Barcelona, Spain. Speakers: Morgan Laloux, Business Development Manager.
Capsugel Announces Availability of its Modular Automated Sampling Technology (Mast) System
Feb 8 17
Capsugel announced the broad commercial availability of its Modular Automated Sampling Technology (MAST) system, which directly transfers samples from bioreactors to analytical devices while maintaining process sterility. This first-of-its-kind technology allows aseptic collection of accurate, representative samples that generate detailed process information in real-time. MAST represents the latest innovation developed by Capsugel to address biopharmaceutical product development and processing challenges MAST provides a modular system that is readily scalable and suitable for use throughout the product development process. The system instantaneously provides a wide range of information at the molecular level for media, cells and bioreactor products, allowing for rapid response to maintain optimum bioreactor conditions and maximize yields. The commercial availability of the technology is the culmination of a focused five-year program conducted by Capsugel's Bend, Ore. facility, in collaboration with several of the biopharmaceutical companies. The company has also developed alliances with numerous analytical equipment suppliers to facilitate process analytical technology (PAT) integration into bioprocessing through MAST. MAST provides for tailored system design and can be readily expanded with additional sampling modules as required. MASTconnect™ software allows for configurable, flexible and user-friendly operation of the MAST system, with special modules for sample scheduling, sample navigation and analytical data management.
Lonza And KKR In Talks To Acquire Capsugel For $5 Billion.
Dec 12 16
Lonza Group Ltd (SWX:LONN) on Monday confirmed that it is in advanced talks with private equity firm KKR & Co. L.P. (NYSE:KKR) to acquire Capsugel Inc. Potential transaction would be valued at more than $5 billion.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|